Our results suggest that the IL-7/IL-7R/JAK pathway is an important molecular pathway for IL-7 to regulate CD28- CTLs in IgG4-RD, and our study proposes a molecular mechanism by which IL-7 regulates CTL levels. This evidence concerns the gene IL7R and immunoglobulin G4-related sclerosing disease.